Envía por correo este artículo 
Terapia Hormonal en la Menopausia: Efectos a corto y Largo Plazo en la Salud
Resumen
La mujer experimenta diferentes etapas a lo largo de su vida, una de ellas es la menopausia, marcada por la disminución de la función ovárica y los niveles hormonales. Durante décadas, la terapia hormonal de la menopausia (THM) se ha empleado con el fin de aliviar los síntomas asociados a esta transición y prevenir las complicaciones a largo plazo derivadas del déficit hormonal. El estudio pretende analizar los efectos a corto y largo plazo de la THM mediante una revisión sistemática de la literatura científica actualizada. Se realizaron búsquedas exhaustivas en bases de datos como Cochrane, PubMed y SCOPUS. Los resultados evaluando la THM en la reducción de los síntomas vasomotores a corto plazo y como método preventivo de la osteoporosis a largo plazo. Sin embargo, también se asocia con ciertos riesgos y efectos secundarios. La decisión de utilizar la THM debe basarse en una evaluación individualizada de los beneficios y riesgos para cada paciente.
Palabras clave
Referencias
Zhu D, Chung HF, Dobson AJ, Pandeya N, Giles GG, Bruinsma F, et al. Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data. Lancet Public Health. 2019 Nov;4(11):e553–64.
Hamoda H, Panay N, Pedder H, Arya R, Savvas M. The British Menopause Society & Women’s Health Concern 2020 recommendations on hormone replacement therapy in menopausal women. Post Reprod Health. 2020 Dec 12;26(4):181–209.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. Declaración PRISMA 2020: una guía actualizada para la publicación de revisiones sistemáticas. Rev Esp Cardiol. 2021 Sep;74(9):790–9.
Vinogradova Y, Coupland C, Hippisley-Cox J. Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases. BMJ. 2019 Jan 9;k4810.
Weller SC, Davis JW, Porterfield L, Chen L, Wilkinson G. Hormone exposure and venous thromboembolism in commercially insured women aged 50 to 64 years. Res Pract Thromb Haemost. 2023 Mar;7(3):100135.
Sundell M, Spetz Holm AC, Fredrikson M, Hammar M, Hoffmann M, Brynhildsen J. Pulmonary embolism in menopausal hormone therapy: a population-based register study. Climacteric. 2022;25(6):615–21.
Collaborative Group on Hormonal Factors in Breast Cancer. Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence. The Lancet. 2019 Sep;394(10204):1159–68.
Poggio F, Del Mastro L, Bruzzone M, Ceppi M, Razeti MG, Fregatti P, et al. Safety of systemic hormone replacement therapy in breast cancer survivors: a systematic review and meta-analysis. Breast Cancer Res Treat. 2022 Jan 3;191(2):269–75.
Chlebowski RT, Anderson GL, Aragaki AK, Manson JE, Stefanick ML, Pan K, et al. Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women’s Health Initiative Randomized Clinical Trials. JAMA. 2020 Jul 28;324(4):369.
Doll C, Hofmann E, Preissner R, Heiland M, Seeland U, Konietschke F, et al. Exogenous Estrogen in the Development of Head and Neck Cancer. JAMA Otolaryngology–Head & Neck Surgery. 2024 Mar 28;
Gartlehner G, Patel S V., Reddy S, Rains C, Schwimmer M, Kahwati L. Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons. JAMA. 2022 Nov 1;328(17):1747.
Li L, Pei B, Feng Y. Exogenous hormone therapy and non-melanoma skin cancer (keratinocyte carcinoma) risk in women: a systematic review and meta-analysis. BMC Cancer. 2023 Oct 6;23(1):946.
Zhu D, Chung HF, Dobson AJ, Pandeya N, Giles GG, Bruinsma F, et al. Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data. Lancet Public Health. 2019 Nov;4(11):e553–64.
Sheedy AN, Wactawski-Wende J, Hovey KM, LaMonte MJ. Discontinuation of hormone therapy and bone mineral density: does physical activity modify that relationship? Menopause. 2023 Dec;30(12):1199–205.
Pourhadi N, Mørch LS, Holm EA, Torp-Pedersen C, Meaidi A. Menopausal hormone therapy and dementia: nationwide, nested case-control study. BMJ. 2023 Jun 28;e072770.
Vinogradova Y, Dening T, Hippisley-Cox J, Taylor L, Moore M, Coupland C. Use of menopausal hormone therapy and risk of dementia: nested case-control studies using QResearch and CPRD databases. BMJ. 2021 Sep 29;n2182.
Savolainen-Peltonen H, Rahkola-Soisalo P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O, et al. Use of postmenopausal hormone therapy and risk of Alzheimer’s disease in Finland: nationwide case-control study. BMJ. 2019 Mar 6;l665.
Jee D, Park SH, Hwang HS, Kim HS, Kim MS, Kim EC. Effects of hormone replacement therapy on lens opacity, serum inflammatory cytokines, and antioxidant levels. Ann Med. 2021 Jan 22;53(1):707–14.
Malik R, Meghana Reddy P. Effectiveness of Tibolone in Relieving Postmenopausal Symptoms for a Short-Term Period in Indian Women. The Journal of Obstetrics and Gynecology of India. 2023 Jun 11;73(3):242–7.
Meziou N, Scholfield C, Taylor CA, Armstrong HL. Hormone therapy for sexual function in perimenopausal and postmenopausal women: a systematic review and meta-analysis update. Menopause. 2023 Jun;30(6):659–71.
Lara LA, Cartagena-Ramos D, Figueiredo JB, Rosa-e-Silva ACJ, Ferriani RA, Martins WP, et al. Hormone therapy for sexual function in perimenopausal and postmenopausal women. Cochrane Database of Systematic Reviews. 2023 Aug 24;2023(8).
Palacios S, Sánchez-Borrego R, Suárez Álvarez B, Lugo Salcedo F, González Calvo AJ, Quijano Martín JJ, et al. Impact of vulvovaginal atrophy therapies on postmenopausal women’s quality of life in the CRETA study measured by the Cervantes scale. Maturitas. 2023 Jun;172:46–51.
Feng P, Lin L, Wang Y, Chen L, Min J, Xie Y, et al. Impacts of menopause hormone therapy on mood disorders among postmenopausal women. Climacteric. 2022 Nov 2;25(6):579–85.
Genazzani AR, Divakar H, Khadilkar SS, Monteleone P, Evangelisti B, Galal AF, et al. Counseling in menopausal women: How to address the benefits and risks of menopause hormone therapy. A FIGO position paper. International Journal of Gynecology & Obstetrics. 2024 Feb 4;164(2):516–30.
van Driel C, Stuursma A, Schroevers M, Mourits M, de Bock G. Mindfulness, cognitive behavioural and behaviour‐based therapy for natural and treatment‐induced menopausal symptoms: a systematic review and meta‐analysis. BJOG. 2019 Feb 15;126(3):330–9.
Nerattini M, Jett S, Andy C, Carlton C, Zarate C, Boneu C, et al. Systematic review and meta-analysis of the effects of menopause hormone therapy on risk of Alzheimer’s disease and dementia. Front Aging Neurosci [Internet]. 2023 Oct 23;15. Available from: https://www.frontiersin.org/articles/10.3389/fnagi.2023.1260427/full
Madsen TE, Sobel T, Negash S, Shrout Allen T, Stefanick ML, Manson JE, et al. A Review of Hormone and Non-Hormonal Therapy Options for the Treatment of Menopause. Int J Womens Health. 2023 May;Volume 15:825–36.
Gartlehner G, Patel S V., Reddy S, Rains C, Schwimmer M, Kahwati L. Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons. JAMA. 2022 Nov 1;328(17):1747.
Zhang GQ, Chen JL, Luo Y, Mathur MB, Anagnostis P, Nurmatov U, et al. Menopausal hormone therapy and women’s health: An umbrella review. PLoS Med. 2021 Aug 2;18(8):e1003731.
Scavello I, Maseroli E, Di Stasi V, Vignozzi L. Sexual Health in Menopause. Medicina (B Aires). 2019 Sep 2;55(9):559.
Andreu Y, Soto-Rubio A, Ramos-Campos M, Escriche-Saura A, Martínez M, Gavilá J. Impact of hormone therapy side effects on health-related quality of life, distress, and well-being of breast cancer survivors. Sci Rep. 2022 Nov 4;12(1):18673.
Hurtado-Martínez L, Saldarriaga-Giraldo CI, Jaramillo-Jaramillo LI, Hormaza-Ángel MP. Riesgo cardiovascular durante la menopausia: una visión del cardiólogo y del ginecólogo. Revista Colombiana de Cardiología. 2022 Feb 1;29(1).
Amancha Moyulema GL, Fernández Nieto MI. Analysis of menopause and application of hormone therapy as therapeutic management. Enfermería Cuidándote. 2024;7.
Johansson T, Fowler P, Ek WE, Skalkidou A, Karlsson T, Johansson Å. Oral Contraceptives, Hormone Replacement Therapy, and Stroke Risk. Stroke. 2022 Oct;53(10):3107–15.
Silva TR, Oppermann K, Reis FM, Spritzer PM. Nutrition in Menopausal Women: A Narrative Review. Nutrients. 2021 Jun 23;13(7):2149.
DOI: https://doi.org/10.23857/pc.v9i7.7910
Enlaces de Referencia
- Por el momento, no existen enlaces de referencia
Polo del Conocimiento
Revista Científico-Académica Multidisciplinaria
ISSN: 2550-682X
Casa Editora del Polo
Manta - Ecuador
Dirección: Ciudadela El Palmar, II Etapa, Manta - Manabí - Ecuador.
Código Postal: 130801
Teléfonos: 056051775/0991871420
Email: polodelconocimientorevista@gmail.com / director@polodelconocimiento.com
URL: https://www.polodelconocimiento.com/
